Goeckerman therapy: a very effective, yet often forgotten treatment for severe generalized psoriasis

References

• Christophers E. Psoriasis–epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314–320.
   PubMed Web of Science ®Google Scholar
• Marsico AR, Eaglstein WH, Weinstein GD. Ultraviolet light and tar in the Goeckerman treatment of psoriasis. Arch Dermatol. 1976;112:1249–1250.
   PubMed Web of Science ®Google Scholar
• Petrozzi JW, Barton JO, Kaidbey KK, Kligman AM. Updating the Goeckerman regimen for psoriasis. Br J Dermatol. 1978;98:437–444.
   PubMedGoogle Scholar
• WH G. The treatment of psoriasis. Northwest Med. 1925;24:229–231.
   Google Scholar
• Lowe NJ, Breeding JH, Wortzman MS. New coal tar extract and coal tar shampoos. Evaluation by epidermal cell DNA synthesis suppression assay. Arch Dermatol. 1982;118:487–489.
   PubMedGoogle Scholar
• Finch PW, Murphy F, Cardinale I, Krueger JG. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol. 1997;151:1619–1628.
   PubMed Web of Science ®Google Scholar
• Fiala Z, Borska L, Pastorkova A, Genotoxic effect of Goeckerman regimen of psoriasis. Arch Dermatol Res. 2006;298:243–251.
   PubMedGoogle Scholar
• Arbiser JL, Govindarajan B, Battle TE, Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. J Invest Dermatol. 2006;126:1396–1402.
   PubMed Web of Science ®Google Scholar
• Krueger JG, Wolfe JT, Nabeya RT, Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med. 1995;182:2057–2068.
   PubMed Web of Science ®Google Scholar
• Ozawa M, Ferenczi K, Kikuchi T, 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189:711–718.
   PubMed Web of Science ®Google Scholar
• Comaish JS. Tar and related compounds in the therapy of psoriasis. Clin Exp Dermatol. 1981;6:639–645.
   PubMed Web of Science ®Google Scholar
• Le Vine MJ, White HA, Parrish JA. Components of the Goeckerman regimen. J Invest Dermatol. 1979;73:170–173.
   PubMedGoogle Scholar
• Muller SA, Kierland RR. Crude coal tar in dermatologic therapy. Mayo Clin Proc. 1964;39:275–280.
   PubMedGoogle Scholar
• Perry HO, Soderstrom CW, Schulze RW. The Goeckerman treatment of psoriasis. Arch Dermatol. 1968;98:178–182.
   PubMed Web of Science ®Google Scholar
• Harber LC, Armstrong RB, Leach EE, Walther RR, Fleiss JL. Preliminary report: modified Goeckerman therapy for hospitalized patients: ambulatory day care center and improved quantitative dosimetry. J Invest Dermatol. 1981;77:162–166.
   PubMedGoogle Scholar
• Armstrong RB, Leach EE, Fleiss JL, Harber LC. Modified Goeckerman therapy for psoriasis. a two-year follow-up of a combined hospital-ambulatory care program. Arch Dermatol. 1984;120:313–318.
   PubMedGoogle Scholar
• Cram DL, King RI. Psoriasis day care centers. JAMA. 1976;235:177–178.
   PubMedGoogle Scholar
• Cram DL. Psoriasis day care center. Int J Dermatol. 1975;14:577–578.
   PubMedGoogle Scholar
• Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol. 1999;41:51–59.
   PubMed Web of Science ®Google Scholar
• Menter A, Cram DL. The Goeckerman regimen in two psoriasis day care centers. J Am Acad Dermatol. 1983;9:59–65.
   PubMed Web of Science ®Google Scholar
• Feldman SR. Where has Goeckerman treatment gone? J Dermatolog Treat. 2005;16:73–74.
   PubMed Web of Science ®Google Scholar
• de Miguel R, el-Azhary R. Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis. Int J Dermatol. 2009;48:653–658.
   PubMedGoogle Scholar
• Lee E, Koo J. Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J Dermatolog Treat. 2005;16:102–107.
   PubMed Web of Science ®Google Scholar
• Menkes A, Stern RS, Arndt KA. Psoriasis treatment with suberythemogenic ultraviolet B radiation and a coal tar extract. J Am Acad Dermatol. 1985;12:21–25.
   PubMed Web of Science ®Google Scholar
• Frost P, Horwitz SN, Caputo RV, Berger SM. Tar gel-phototherapy for psoriasis. combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation. Arch Dermatol. 1979;115:840–846.
   PubMedGoogle Scholar
• Lowe NJ, Wortzman MS, Breeding J, Koudsi H, Taylor L. Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. J Am Acad Dermatol. 1983;8:781–789.
   PubMed Web of Science ®Google Scholar
• Bagel J. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. J Drugs Dermatol. 2009;8:351–357.
   PubMed Web of Science ®Google Scholar
• Muller SA, Perry HO. The Goeckerman treatment in psoriasis: six decades of experience at the mayo clinic. Cutis. 1984;34:265–268; 70.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Young DW. Short contact crude coal tar therapy for psoriasis. Clin Exp Dermatol. 1985;10:371–374.
   PubMedGoogle Scholar
• Stern RS, Zierler S, Parrish JA. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet. 1980;1:732–735.
   PubMed Web of Science ®Google Scholar
• Pittelkow MR, Perry HO, Muller SA, Maughan WZ, O'Brien PC. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol. 1981;117:465–468.
   PubMed Web of Science ®Google Scholar